Greece's medicines regulator, founded in 1983 under Law 1316. New cancer medicines are authorised for the whole EU through the European Medicines Agency; EOF supervises them on the Greek market, authorises clinical trials and runs pharmacovigilance.
The organisation's own profile says the Εθνικός Οργανισμός Φαρμάκων was founded in 1983 by Law 1316 as a public-law body of the Ministry of Health, with the mission of protecting public health by ensuring the safety, quality and efficacy of medicines for human and veterinary use, biological products, medical devices, food supplements, biocides and cosmetics on the Greek market. Working with the European Union, it evaluates and authorises products, monitors their quality, safety and efficacy after they are marketed, inspects manufacturing, clinical studies and distribution against good practice rules, promotes medical and pharmaceutical research, and informs health professionals and the public. Its site has pages on clinical trials, on clinical studies of medical devices, and on the national ethics committee.
New active substances for cancer go through the EU centralised procedure, so a medicine authorised by the European Commission is legally available in Greece at the same time as elsewhere in the EU; reimbursement is decided separately, through the national committee for the evaluation and reimbursement of medicines and the insurer. The coordinates are a city point for Athens.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/